Bayer AG, Johnson & Johnson Face Calls To Consolidate Xarelto Blood-Thinner Suits

Bayer AG (BAYN) and Johnson & Johnson (JNJ) are fighting calls to consolidate lawsuits over a blood-thinning drug blamed for causing some patients to bleed to death after a settlement this year by the maker of a competing product.

Patients who took Xarelto accuse the drugmakers of downplaying the medicine’s bleeding risks and asked that the cases be gathered before U.S District Judge David Herndon in East St. Louis, Illinois, for pretrial information exchanges, according to court filings. Consumers contend 65 deaths have been linked to bleeding caused by the drug, which has no antidote, according to court filings.

Help employers find you! Check out all the jobs and post your resume.

Back to news